HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Harold Ballard Selected Research

Neoplasms (Cancer)

7/2008Intravenous iron: from anathema to standard of care.
4/2004Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Harold Ballard Research Topics

Disease

4Anemia
10/2011 - 04/2004
2Neoplasms (Cancer)
07/2008 - 04/2004
1Infections
01/2010
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/2010
1Iron Deficiencies
01/2010
1Multiple Myeloma
11/2009
1Kidney Diseases (Kidney Disease)
04/2004

Drug/Important Bio-Agent (IBA)

4IronIBA
10/2011 - 04/2004
2Hemoglobins (Hemoglobin)IBA
07/2008 - 04/2004
1Iron-Dextran Complex (InFed)FDA Link
10/2011
1Dextrans (Dextran)FDA Link
10/2011
1ferryl iron (Fe(4+))IBA
07/2008
1Ferritins (Ferritin)IBA
04/2004
1Transferrin (beta 2 Transferrin)IBA
04/2004
1ErythropoietinFDA Link
04/2004

Therapy/Procedure

3Drug Therapy (Chemotherapy)
07/2008 - 04/2004
2Therapeutics
01/2010 - 07/2008
1Stem Cell Transplantation
11/2009